Effectiveness and Safety of Vemurafenib as Monotherapy in Unresectable or Metastatic Melanoma from an Academic Database- Real World Data to Strengthen Evidence for Payer

Abstract

Authors

I Borget S Dalle M Leccia C Dutriaux P Stoebner S Dalac F Aubin P Saiag JP Lacour T Lesimple A Dupuy L Mortier M Beylot-Barry E Maubec V Descamps C Lok A Stephan B Guillot J de Quatrebarbes B Dreno S Gally M Mouri C Allayous A Kowal R Porcher C Lebbe

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×